1989 Bachelor in Medicine
Radiological Medicine, Norman Bethune University of Medical Science　　
1997-2000 Ph. D of  Oncological Radiotherapy
Oncological radiotherapy, Université Paris XII Créteil Val de Marne 

（1）C. Lin, X.-S. Sun, S.-L. Liu, X.-Y. Li, N. Lu, X.-L. Li, L.-Q. Tang, L. Guo, Establishment and Validation of a Nomogram for Nasopharyngeal Carcinoma Patients Concerning the Prognostic Effect of Parotid Lymph Node Metastases, Cancer Research and Treatment 52(3) (2020) 855-866. 
（2）S.-L. Liu, H.-X. Lin, C.-Y. Lin, X.-Q. Sun, L.-P. Ye, F. Qiu, W. Wen, X. Hua, X.-Q. Wu, J. Li, L.-B. Song, L. Guo, TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/beta-catenin signaling pathway and promoting the epithelial mesenchymal transition (vol 402, pg 117, 2021), Cancer Letters 524 (2022) 284-285. 
（3） H.-Z. Qiu, X. Zhang, S.-L. Liu, X.-S. Sun, Y.-W. Mo, H.-X. Lin, Z.-J. Lu, J. Guo, L.-Q. Tang, H.-Q. Mai, L.-T. Liu, L. Guo, M1 stage subdivisions based on F-18-FDG PET-CT parameters to identify locoregional radiotherapy for metastatic nasopharyngeal carcinoma, Therapeutic Advances in Medical Oncology 14 (2022). 
（4） Gu, L.-w., X. Zhang, J. Zhang, B.-b. Xiao, L.-p. Wu, L.-q. Tang, L. Guo & L.-t. Liu (2024) The prognostic value of pretreatment 18F-FDG PET-CT parameters with peripheral blood markers in patients with de novo metastatic nasopharyngeal carcinoma. Oral Oncology, 156, 106928.
（5） Guo, J., Y. He, C. Lin, Q. Jiang, H.-W. Xing, Y.-C. Zhang, G.-Z. Shen, H.-X. Lin, L. Guo & Q. Yang (2023a) Integrating pretreatment MRI-detected nodal features and Epstein-Barr virus DNA to identify optimal candidates for intensity-modulated radiotherapy alone in patients with stage II nasopharyngeal carcinoma. Oral Oncology, 146, 106574.
（6） Lin, C., N. Lu, J.-L. Liang, J. Guo, L.-W. Gu, R. Sun, L. Guo & Q. Yang (2023) Clinical treatment considerations in the intensity-modulated radiotherapy era for parotid lymph node metastasis in patients with nasopharyngeal carcinoma. Radiotherapy and Oncology, 186, 109802.
（7）Lu, Z.-J., T. Liu, J.-Y. Lin, S.-T. Pei, L. Guo, S.-L. Liu & H.-Q. Mai (2023) Identifying the prognostic value of MRI-based tumor response and predicting the risk of radio-resistance in re-radiotherapy for locally recurrent nasopharyngeal carcinoma. Radiotherapy and Oncology, 183, 109635.
（8）Zhu, Q., A. L. Zhong, H. Hu, J. J. Zhao, D. S. Weng, Y. Tang, Q. Z. Pan, Z. Q. Zhou, M. J. Song, J. Y. Yang, J. Y. He, Y. Liu, M. Li, W. M. Hu, C. P. Yang, T. Xiang, M. Y. Chen, G. Ma, L. Guo & J. C. Xia (2023) Acylglycerol kinase promotes tumor growth and metastasis via activating the PI3K/AKT/GSK3β signaling pathway in renal cell carcinoma. J Hematol Oncol 2020 Jan 3;13(1):2
（9）Jiang, T., H. Sun, T. Xu, S. Xue, W. Xia, X. Xiao, Y. Wang, L. Guo & H. Lin (2024) Significance of Pre-Treatment CALLY Score Combined with EBV-DNA Levels for Prognostication in Non-Metastatic Nasopharyngeal Cancer Patients: A Clinical Perspective. Journal of Inflammation Research, 17, 3353-3369.
（10）Chen, X. Y., Z. Q. Long, H. Y. Huang, W. Wen, F. Lin, L. Guo & H. X. Lin (2023) Predicting Survival of Patients with Nonmetastatic Breast Cancer Based on Fibrinogen-to-Albumin Ratio and Lymphocyte-to-Monocyte Ratio: A Nomogram-Based Assessment. Breast Care, 18, 374-389.

Updated by International Office, Sun Yat-sen University Cancer Center